4Hildebrandt E F, Lee J R, Crosby J H, et al. Liquid-based papsmears as a source of RNA for gene expression analysis[J]. Ap-plimmunohistochem Moli Morphol. 2003,11(4)丨 345-351.
6GUO Ming. Hu Lu-lin. Martin L, et al. Accuracy of liquid-based Pap tests : Comparison of concurrent liquid-based tests andcervical biopsies on 782 women with previously abnormal Papsmears[J]. Aeta Cytol, 2005, 49(2) : 132-138.
3Baek M H, Park J Y, Kim D, et al. Comparison of adenocarci- noma and adenosquamous carcinoma in patients with early-stage cervical cancer after radical surgery [J]. Gyneeol Oneol, 2014, 135(3) :462-467.
4DiMaio D. Nuns Warts Viruses and Cancer [J]. Yale J Biol Med, 2015,88(2) :127-129.
5Suh D H, Lee K H, Kim K, et al. Major clinical research ad- vances in gynecologic cancer in 2014 [J]. J Gyneeol Oncol, 2015,26(2) : 156-167.
6Teke F, Yoney A, Teke M, et al. Lack of any impact of histo- pathology type on prognosis in patients with early-stage adeno- carcinoma and squamous cell carcinoma of the uterine cervix [J]. Asian Pac J Cancer Prev, 2014,15(6) :2815-2819.
7Chase D, Goulder A, Zenhausern F, etal. The vaginal and gas- trointestinal microbiomes in gynecologic cancers: A review of applications in etiology, symptoms and treatment [J]. Gynecol Oncol, 2015,138(1) : 190-200.
8Thaxton L, Waxman A G. Cervical cancer prevention: immuni- zation and screening 2015 [J]. Med Clin North Am, 2015,99 (3) :469-477.
9Dasari S, Wudayagiri R, Valluru L. Cervical cancer: Biomarkers for diagnosis and treatment [J].Clin Chim Acta, 2015, 445:7-11.
10Arbyn M, Castellsague X, de Sanjose S, et al. Worldwide bur- den of cervical cancer in 2008 [J]. Ann Oncol, 2011,22 (12): 2675-2686.
